Drug firm Lupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in treating diabetes.
The company's US-based subsidiary Lupin
Lupin Q3 up 5% at `235 cr
Drug firm Lupin today said its consolidated net profit rose by 4. 95 per cent to Rs 235
Mumbai-headquartered drugmaker Lupin has been sued by Allergan in a US court over its plans for a generic version of Allergan’s Acular LS solution. Lupin is planning to come
Mumbai-headquartered pharma firm Lupin is eyeing the lucrative US eye drug market literally. For second time this year Lupin has been sued for wanting to sell generic
Lupin plans to spend `230 cr on Indian plant
Pharma firm Lupin today said it has launched a generic version of Femcon Fe, birth control chewable tablets, in the US market.
It's US-based subsidiary Lupin Pharmaceuticals Inc has launched
Takeda Pharmaceutical Co, Japan's largest drugmaker, is in talks with Indian generic drugmakers Cipla and Lupin about buying one of the companies' pharmaceutical businesses, a business daily reported on Wednesday.
Stay informed on our latest news!
